These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 1136209

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Dialysis and per cent elimination of different cardiac glycosides during haemo- and peritonealdialysis].
    Kramer P, Quellhorst E, Horenkamp J, Scheler F.
    Klin Wochenschr; 1972 Jun 15; 50(12):609-13. PubMed ID: 5052656
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [On the problem of cardiac glycoside accumulation].
    Kuschinsky K.
    Dtsch Med Wochenschr; 1968 Nov 29; 93(48):2344-7. PubMed ID: 4881347
    [No Abstract] [Full Text] [Related]

  • 8. [Renal elimination kinetics of various several cardiac glycosides].
    Kramer P, Scheler F.
    Dtsch Med Wochenschr; 1972 Oct 06; 97(40):1485-90. PubMed ID: 5071762
    [No Abstract] [Full Text] [Related]

  • 9. [Cardiac glycoside receptor affinity and (Na++K+)-ATPase inhibition of digitoxin, digoxin, methyldigoxin, strophanthin, proscillaridin, and meproscillarin. Measurements on isolated human cardiac cell membranes].
    Erdmann E.
    Arzneimittelforschung; 1978 Oct 06; 28(3a):531-5. PubMed ID: 148278
    [No Abstract] [Full Text] [Related]

  • 10. [Correction of the incorrectly measured Hatcher-Brody optimal titer of cardiotonic steroids. Determination of the molar optimal titer at long survival time].
    Vogel G.
    Naunyn Schmiedebergs Arch Pharmakol; 1969 Oct 06; 264(3):320. PubMed ID: 4242454
    [No Abstract] [Full Text] [Related]

  • 11. Tissue distribution, metabolism and elimination of cardiac glycosides.
    van Zwieten PA.
    Ger Med Mon; 1968 Jul 06; 13(7):346-9. PubMed ID: 4879650
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Recent aspects of therapy with cardiac glycosides].
    Bayer O, Jost F.
    Dtsch Med J; 1970 May 19; 21(10):675-6 passim. PubMed ID: 5523167
    [No Abstract] [Full Text] [Related]

  • 17. [Kinetics of cardiac steroids in man and experimental animals].
    Ruiz-Torres A.
    Klin Wochenschr; 1970 Mar 01; 48(5):257-70. PubMed ID: 4943080
    [No Abstract] [Full Text] [Related]

  • 18. Digitalis pharmacokinetics and therapy with respect to impaired renal function.
    Kramer P.
    Klin Wochenschr; 1977 Jan 01; 55(1):1-11. PubMed ID: 319291
    [Abstract] [Full Text] [Related]

  • 19. [Intestinal absorption of cardiac glycosides in vitro and in vivo].
    Forth W, Furukawa E, Rummel W.
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1969 Jan 01; 262(1):53-72. PubMed ID: 4237042
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.